- Investing Ideas
- /
- Taiwanese Biotech Stocks
Taiwanese Biotech Stocks
Results
55
55 companies
PharmaEssentia
Market Cap: NT$186.5b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$560.00
7D
-0.4%
1Y
72.0%
Caliway Biopharmaceuticals
Market Cap: NT$138.4b
Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease.
6919
NT$900.00
7D
0.2%
1Y
271.5%
Bora Pharmaceuticals
Market Cap: NT$80.1b
Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.
6472
NT$779.00
7D
0.3%
1Y
24.6%
Lotus Pharmaceutical
Market Cap: NT$66.3b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$250.00
7D
-2.2%
1Y
-15.1%
Sunmax Biotechnology
Market Cap: NT$20.3b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$373.00
7D
4.5%
1Y
73.5%
TTY Biopharm
Market Cap: NT$19.7b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$79.40
7D
-0.4%
1Y
-2.9%
Medigen Vaccine Biologics
Market Cap: NT$17.7b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$53.80
7D
0.6%
1Y
0.6%
PharmaEngine
Market Cap: NT$15.3b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$105.00
7D
0%
1Y
4.0%
YungShin Global Holding
Market Cap: NT$15.0b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, the United States, Mainland China, and Japan.
3705
NT$56.20
7D
0.4%
1Y
17.5%
Synmosa Biopharma
Market Cap: NT$14.4b
A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.
4114
NT$34.15
7D
-0.4%
1Y
-4.0%
Handa Pharmaceuticals
Market Cap: NT$12.1b
A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China.
6620
NT$85.80
7D
0.1%
1Y
-48.3%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.3b
Standard Chemical & Pharmaceutical Co. Ltd.
1720
NT$63.10
7D
0.3%
1Y
-4.5%
Acepodia
Market Cap: NT$11.3b
Operates as a clinical stage biotechnology company.
6976
NT$19.65
7D
-6.4%
1Y
-33.3%
SCI Pharmtech
Market Cap: NT$9.9b
Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.
4119
NT$82.90
7D
-1.1%
1Y
-5.4%
Adimmune
Market Cap: NT$9.1b
Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.
4142
NT$21.55
7D
-2.5%
1Y
-19.4%
Formosa Laboratories
Market Cap: NT$8.9b
Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.
4746
NT$74.00
7D
2.9%
1Y
-27.8%
Mycenax Biotech
Market Cap: NT$8.4b
A contract development and manufacturing organization company, provides biopharmaceutical services and solutions for drug development and production in Taiwan, Japan, Korea, Singapore, rest of the Asia-Pacific regions, Europe, and the United States.
4726
NT$40.80
7D
-1.2%
1Y
8.7%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.8b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$31.95
7D
1.1%
1Y
-4.4%
Cenra
Market Cap: NT$5.6b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$38.00
7D
1.2%
1Y
n/a
Medigen Biotechnology
Market Cap: NT$4.8b
A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.
3176
NT$34.60
7D
-1.4%
1Y
-14.6%
SYN-TECH Chem. & Pharm
Market Cap: NT$4.7b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$104.50
7D
-3.2%
1Y
25.3%
AP Biosciences
Market Cap: NT$4.6b
A clinical-stage biopharmaceutical company, researches and develops bispecific antibody drugs for unmet medical needs.
6945
NT$53.80
7D
-1.1%
1Y
-12.1%
Orient EuroPharma
Market Cap: NT$4.4b
A pharmaceutical company, develops and manufactures drugs worldwide.
4120
NT$50.50
7D
0.4%
1Y
19.1%
Nang Kuang Pharmaceutical
Market Cap: NT$4.3b
Together with its subsidiary, engages in the manufacturing, processing, trading, import, and export of pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.
1752
NT$42.50
7D
-0.7%
1Y
-9.6%
Maxigen Biotech
Market Cap: NT$4.0b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$44.60
7D
-1.8%
1Y
-2.8%
BioGend Therapeutics
Market Cap: NT$4.0b
Researches, develops, and sells orthopedic medical equipment and related products.
6733
NT$31.80
7D
-0.9%
1Y
-15.3%
BRIM Biotechnology
Market Cap: NT$3.7b
A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.
6885
NT$28.25
7D
-3.9%
1Y
-17.6%
HeXun Biosciences
Market Cap: NT$3.7b
Engages in the research and development of stem cell and treatments in Taiwan.
6986
NT$79.50
7D
-12.9%
1Y
45.1%
Syngen BiotechLtd
Market Cap: NT$3.5b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$130.00
7D
1.6%
1Y
-19.3%
TCM Biotech International
Market Cap: NT$3.3b
A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.
4169
NT$56.70
7D
-1.7%
1Y
7.0%
Shine-On BioMedicalLtd
Market Cap: NT$3.3b
Research, develops, and manufactures anti-cancer related drug products.
6926
NT$65.80
7D
0.5%
1Y
2.3%
GlycoNex Incorporation
Market Cap: NT$2.6b
Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.
4168
NT$23.95
7D
-0.2%
1Y
-4.4%
Chunghwa Chemical Synthesis & Biotech
Market Cap: NT$2.6b
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
1762
NT$33.15
7D
0.9%
1Y
-33.6%
Gwo Xi Stem Cell Applied Technology
Market Cap: NT$2.4b
Develops stem cell medicines for patients with unmet medical needs.
6704
NT$25.00
7D
-1.8%
1Y
-16.7%
TSH Biopharm
Market Cap: NT$2.2b
Develops and markets pharmaceutical products in Taiwan and Asia.
8432
NT$57.40
7D
-0.5%
1Y
-0.3%
Great Novel Therapeutics Biotech & Medicals
Market Cap: NT$2.0b
Engages in the development of drugs for the treatment of advanced and refractory cancers.
7427
NT$46.15
7D
4.9%
1Y
-1.2%